R

RXRX

Recursion Pharmaceuticals, Inc.

3.510

+0.010+0.29%
After Hours: 3.520  +0.010  +0.28%19:59 04/24 EDT

Financial Statements

Statement:

Key indicator

Income Statement

Balance Sheet

Cash Flow

Reporting Period:

Accumulated Report

FY

YoY:
FY: Financial Year Annual Report
Q: Quarter is quarterly reports. Q1, Q2, Q3 and Q4 are reports for a single quarter. Q6 and Q9 are accumulated quarterly reports, respectively contain 6 months' reports and 9 months' report.
Item
FY 2025
FY 2024
FY 2023
FY 2022
FY 2021
Total Revenue

74.68M

58.84M

44.58M

39.84M

10.18M

Net Income

-644.76M

-463.66M

-328.07M

-239.48M

-186.48M

ROE

-0.5954

-0.6189

-0.6912

-0.4656

-0.4751

ROA

-0.4412

-0.4411

-0.4842

-0.3652

-0.4103

EPS

-1.441

-1.6909

-1.5784

-1.3642

-1.4877

BVPS

2.1443

2.6098

1.9821

2.5432

3.1886

Asset Turnover

0.0511

0.056

0.0658

0.0608

0.0224

Debt-to-Asset

0.2329

0.2857

0.2911

0.3073

0.1104

Current Ratio

5.5031

3.81

4.7025

5.6831

11.4604

Quick Ratio

--

--

--

--

--